Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2009 Results
Date:1/28/2010

ting current products; rate of sales growth of recently launched products; the timing of anticipated regulatory approvals and launches of new products; regulatory actions regarding currently marketed products; other regulatory developments and government investigations; patent disputes and other litigation involving current and future products; the impact of governmental actions regarding pricing, importation, and reimbursement for pharmaceuticals, including proposed health care reform currently being discussed by the U.S. Congress; changes in tax law; asset impairments and restructuring charges; acquisitions and business development transactions; and the impact of exchange rates and global macroeconomic conditions. For additional information about the factors that affect the company's business, please see the company's latest Form 10-Q filed October 2009 and Form 10-K filed February 2009. The company undertakes no duty to update forward-looking statements.

Alimta® (pemetrexed, Lilly)

Byetta® (exenatide injection, Amylin Pharmaceuticals)

Cialis® (tadalafil, Lilly)

Cymbalta® (duloxetine hydrochloride, Lilly)

Effient (prasugrel, Lilly)

Erbitux® (cetuximab, ImClone Systems, Lilly)

Evista® (raloxifene hydrochloride, Lilly)

Forteo® (teriparatide of recombinant DNA origin injection, Lilly)

Gemzar® (gemcitabine hydrochloride, Lilly)

Humalog® (insulin lispro injection of recombinant DNA origin, Lilly)

Humulin® (human insulin of recombinant DNA origin, Lilly)

Livalo® (pitavastatin, Kowa)

Posilac® (recombinant bovine somatotropin, Lilly)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO ... for the quarter ended June 30, 2015. All comparisons, unless ... Second Quarter 2015 Highlights include: ... $266 million , Total prescriptions dispensed of 234,000, an ... 5.5% , Adjusted EBITDA of $22.7 million, an increase ...
(Date:8/3/2015)... , August 3, 2015 ... 2015 market research with 2020 forecasts as well ... healthcare and medical devices intelligence collection of its ... simulation market with 2020 forecasts spread across 164 ... with 170 tables and figures is now available ...
(Date:8/3/2015)... 3, 2015  Sage Analytics ( www.sageanalytics.com ), the ... potency measurement systems, announced its sponsorship of the California ... A limited number of tickets are available for groups ... great cause while enjoying an open bar, buffet dinner ... San Francisco Bay at sunset. With the ...
Breaking Medicine Technology:Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2
... concept of smaller, thinner laparoscopic tools has been an ... advent of laparoscopic surgery. Some prominent manufacturers of surgical ... they did not perform to the standard that bariatric ... extremely thin instruments would bend under the stress of ...
... TUCSON, Ariz., Aug. 23, 2011 The Muscular Dystrophy ... 40 new research initiatives targeting nearly two dozen ... initiatives targeting Duchenne muscular dystrophy (DMD), nine ... or Lou Gehrig,s disease), as well as efforts on ...
Cached Medicine Technology:New Micro Laparoscopic Instruments for the Bariatric Surgery Allow for Less Scarring and Pain than Ever Before Possible 2Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants 2Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants 3Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants 4Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants 5
(Date:8/3/2015)... Princeton, NJ (PRWEB) , ... August 03, 2015 ... ... named a finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs ... by and for B2B brands. BESLER Consulting's campaign for the launch of their ...
(Date:8/3/2015)... ... August 03, 2015 , ... A recent survey ... number of Hispanics believe people can positively affect their diabetes, few look beyond ... said making diet changes was important. Far fewer participants mentioned the need for ...
(Date:8/3/2015)... ... August 03, 2015 , ... Social impact organization’s #HelpOneHelpMany ... 2015 – Since winning a South by Southwest® (SXSW®) Interactive Innovation Award in ... whose mission is to develop technology for the sake of humanity – continues ...
(Date:8/3/2015)... , ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: ... is scheduled to present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 ... webcast and subsequent archived replay of the Company’s presentation may be accessed via the ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... A July ... among U.S. emergency rooms in recent years, according to the American Dental Association. According ... of dental emergency visits went from 1.1 million in a single year to 2.2 ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3
... education have a higher incidence of lung cancer compared with ... approximately half of this risk, according to a study in ... the National Cancer Institute. , Previous studies showed that ... for developing lung cancer. Some studies have also suggested that ...
... who experience chest pain are sent to a cardiologist to ... test results show no evidence of coronary artery disease which ... a less common occurrence in men, and these women are ... return to their physicians complaining of similar symptoms and are ...
... being tapped by Jordan, one of the 10 most water-deprived ... times the radiation considered safe for drinking water in a ... "The combined activities of 228 radium and 226 radium ... we tested are up to 2000 percent higher than international ...
... The Hanover Insurance Group, Inc. (NYSE: ... elected to the company,s board of directors at ... is principal of Taggart Associates in Cambridge, Mass., ... her work on corporate and non-profit boards.(Logo: ...
... men discuss use of medicines such as Propecia with their ... with no signs of prostate cancer may wish to talk ... reduce their risk for the disease, new guidelines suggest. , ... Urological Association have issued new guidelines recommending that these men ...
... to aid doctors, , , TUESDAY, Feb. 24 (HealthDay News) -- ... the American Heart Association and the American College of Cardiology ... doctors respect most, a new study finds. , That conclusion ... author of the report, published in the Journal of ...
Cached Medicine News:Health News:Smoking behavior partially explains socioeconomic inequities in lung cancer incidence 2Health News:Cardiologists initiate STILETTO study to investigate treatment options for women with chest pain 2Health News:Jordan's fossil water source has high radiation levels 2Health News:Jordan's fossil water source has high radiation levels 3Health News:The Hanover Insurance Group Elects Harriett Tee Taggart to Board of Directors 2Health News:The Hanover Insurance Group Elects Harriett Tee Taggart to Board of Directors 3Health News:Drugs May Help Healthy Men Lower Prostate Cancer Risk 2Health News:Weak Evidence Backs Most Heart Guidelines, Report Finds 2Health News:Weak Evidence Backs Most Heart Guidelines, Report Finds 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: